Research study Program year 2021 Source: CMS Open Payments

A Phase 3 Randomized, Placebo-Controlled, Double-Blind Program to Evaluate Efficacy and Safety of Upadacitinib in Adult Subjects with Axial Spondyloarthritis Followed by a Remission-Withdrawal Period

ClinicalTrials.gov NCT04169373

Research payments

$2,535,897

407 payments

Through program year 2021, $2,535,897 in research payments was reported against A Phase 3 Randomized, Placebo-Controlled, Double-Blind Program to Evaluate Efficacy and Safety of Upadacitinib in Adult Subjects with Axial Spondyloarthritis Followed by a Remission-Withdrawal Period, across 407 payments, paid by AbbVie, Inc..

Paid by: AbbVie, Inc.
ClinicalTrials.gov: NCT04169373

By program year

1 row

Year	Kind	Amount	Payments
2021	Research	$2,535,897	407

Breakdown

Who paid Research payments · program year 2021

AbbVie, Inc. $2,535,897 407 payments

Who received the money Research payments · program year 2021

Conquest Research Organisation paid for research $412,275 20 payments
Clinical Investigation Specialists INC Organisation paid for research $350,425 39 payments
Arizona Arthritis And Rheumatology Associates Pc Organisation paid for research $247,061 94 payments
Altoona Center For Clincial Research Organisation paid for research $216,971 19 payments
Innovation Medical Research Center INC Organisation paid for research $198,314 12 payments
Newport Huntington Medical Group Organisation paid for research $125,496 13 payments
Sweet Hope Research Specialty INC Organisation paid for research $116,199 16 payments
Interspond Llc Organisation paid for research $106,841 44 payments
Rheumatology And Pulmonary Clinic PLLC Organisation paid for research $104,246 14 payments
Inland Rheumlgy Clinical Trials INC Organisation paid for research $85,399 11 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.